Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Omnicell, Inc. OMCL
$69.97
+$2.19 (3.12%)
На 18:00, 12 мая 2023
+73.89%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
3010257065.00000000
-
week52high
125.17
-
week52low
46.11
-
Revenue
1295947000
-
P/E TTM
-168
-
Beta
0.90276800
-
EPS
0.12000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 авг 2023 г. в 10:59
Описание компании
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Piper Sandler | Overweight | Overweight | 08 авг 2022 г. |
| BTIG | Buy | Buy | 27 июл 2022 г. |
| SVB Leerink | Market Perform | 15 июл 2022 г. | |
| Wells Fargo | Overweight | Overweight | 03 мая 2022 г. |
| Piper Sandler | Overweight | Overweight | 03 мая 2022 г. |
| Keybanc | Overweight | 16 сент 2022 г. | |
| B of A Securities | Buy | 09 сент 2022 г. | |
| Benchmark | Buy | Buy | 23 сент 2022 г. |
| Piper Sandler | Overweight | Overweight | 21 сент 2022 г. |
| BTIG | Buy | Buy | 21 сент 2022 г. |
| Wells Fargo | Overweight | Overweight | 04 ноя 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 03 ноя 2022 г. |
| BTIG | Buy | Buy | 03 ноя 2022 г. |
| Benchmark | Hold | Buy | 03 ноя 2022 г. |
| JP Morgan | Neutral | Neutral | 18 ноя 2022 г. |
| Keybanc | Overweight | Overweight | 02 февр 2023 г. |
| Piper Sandler | Overweight | Overweight | 27 янв 2023 г. |
| Wells Fargo | Overweight | Overweight | 24 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| PARRISH MARK W | D | 0 | 3000 | 28 дек 2022 г. |
| PARRISH MARK W | A | 61459 | 3000 | 28 дек 2022 г. |
| Seidelmann Scott Peter | D | 29788 | 945 | 27 дек 2022 г. |
| PARRISH MARK W | D | 3000 | 3000 | 22 дек 2022 г. |
| PARRISH MARK W | A | 58459 | 3000 | 22 дек 2022 г. |
| Seidelmann Scott Peter | D | 30733 | 1250 | 16 дек 2022 г. |
| Seidelmann Scott Peter | D | 31983 | 3186 | 16 дек 2022 г. |
| Seidelmann Scott Peter | D | 35169 | 3827 | 15 дек 2022 г. |
| Kuipers Peter J. | D | 57130 | 4196 | 15 дек 2022 г. |
| LIPPS RANDALL A | D | 79696 | 8652 | 15 дек 2022 г. |
Новостная лента
Omnicell's (OMCL) New Acquisitions Aid Growth, Cost Woes Stay
Zacks Investment Research
09 мая 2023 г. в 12:13
Omnicell (OMCL) remains well-positioned to meet pharmacy and hospital needs, backed by the recent acquisitions and expansion of its advanced services solutions.
Omnicell (OMCL) Q1 Earnings Top Estimates, Margins Down
Zacks Investment Research
03 мая 2023 г. в 09:07
Despite a year-over-year decrease, Omnicell's (OMCL) first-quarter revenues and earnings exceed the top end of the previously announced outlook amid an uncertain macroeconomic environment.
Omnicell, Inc. (OMCL) Q1 2023 Earnings Call Transcript
Seeking Alpha
02 мая 2023 г. в 20:05
Omnicell, Inc. (NASDAQ:OMCL ) Q1 2023 Results Conference Call May 2, 2023 4:30 PM ET Company Participants Kathleen Nemeth - Head of IR Randall Lipps - Chief Executive Officer Scott Seidelmann - Executive Vice President and Chief Commercial Officer Peter Kuipers - Chief Financial Officer Conference Call Participants Stan Berenshteyn - Wells Fargo Scott Schoenhaus - KeyBanc Matt Hewitt - Craig-Hallum Jessica Tassan - Piper Sandler Stephanie Davis - SVB Allen Lutz - Bank of America David Larsen - BTIG Anne Samuel - JPMorgan Operator Good afternoon. My name is Abby, and I will be your conference operator today.
Omnicell (OMCL) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research
02 мая 2023 г. в 18:23
Omnicell (OMCL) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.83 per share a year ago.
Here's Why Investors Should Retain Omnicell (OMCL) Stock Now
Zacks Investment Research
29 мар 2023 г. в 13:46
Investors are optimistic about Omnicell (OMCL) owing to its planned geographic expansion.